🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💡 Accessing the right #realworlddata for your research can be a challenge. 💡Our latest blog explores how OM1 Aspen shifts away from outdated manual data abstraction so #clinicaltrials can leverage readily available data. 📖 Read the blog: okt.to/JHOeK7

Yesterday at #SCOPESummit we presented on Automated Data Collection for Prospective Research. Stop by booth #328 to learn more about how #AI-powered solutions: ✅ Reduce site & patient burden ✅ Achieve cost savings ✅ Deliver more comprehensive #RWD to achieve better outcomes

🌟 OM1 has joined forces with the AAD DataDerm to create the largest #dermatology data network in the U.S. 🌟 Explore insights from research-ready data that helps researchers reduce burden and streamline clinical research. 📖 View the eBook: okt.to/aWvC4V

🌟 Are you attending the AAD Annual Meeting? Let’s connect to address gaps in #dermatology data for a comprehensive view of the #patientjourney from clinical development to the clinic. 🤝 Find out how we can help you drive more impactful research! okt.to/APnbYh

❤️ This #HeartFailure Awareness Week, we’re highlighting the need for better data to improve detection, treatment, and outcomes. OM1’s #HeartFailure Network uses #RWD and #AI to uncover critical insights into disease progression and care. 📖 Read more: okt.to/mzskfI

🧠 Now Available: Full Manuscript on #TreatmentResistantDepression Insights Explore how #AI transforms unstructured clinical notes from a multi-source real-world #mentalhealth database to estimate #PHQ9 scores. 📍 Read it here: okt.to/dxtCk2 Elsevier News

Introducing: 🎙️🌟 Behind the Insights! A series where industry experts share #RWD, #AI, and evidence generation insights. Our first episode features Joseph Zabinski's insights on #AI in dermatology & the impact on #patientoutcomes. 📍Full episode 👉 okt.to/Ixzbce

💡A new paradigm for #clinicaldata collection is emerging. Our latest blog details how this new paradigm is supported by #regulatory compliant active data collection processes to reduce costs and increase site satisfaction. 📖 Learn more: okt.to/v78zhi

💡Why settle for partial #dermatology insights when you can reveal the full #patientjourney? Access #RWD from 5,000+ providers and 780+ practices, covering conditions like #atopicdermatitis, #hidradenitissuppurativa, and more. Explore whats possible 👉 okt.to/4fyUr3

🫀 Our Heart Belongs to Data🫀 With insights that span millions of patients, our data makes sure your research doesn’t skip a beat. This Valentine’s Day, don’t just match with any data partner—choose one that truly understands your needs. 📍Learn more: okt.to/8xM7RN

🤝 Meet the OM1 team at the AAD Annual Meeting! Stop by booth #2062 or schedule a time to meet and discuss how we can help power your next #dermatology breakthrough, together. 📆 Book your meeting here: okt.to/qMaon9

To drive meaningful impact in #drugdevelopment, researchers need scalable, high-quality, fit-for-purpose data. Our latest blog explores how Aspen supports faster decision-making, deeper insights, and more effective evidence generation. 📖 Read the blog: okt.to/ku0jfJ

🎙️🌟 What if you could shorten the cycle between data insights and clinical impact? Learn how #AI removes the translational process by learning from a patient's past experience before diagnosis and picks up patterns. 📍Full episode okt.to/tjHdsf

🔍 #HidradenitisSuppurativa (HS) research requires a complete view of the #patientjourney, yet many rely on fragmented data that miss critical insights. Uncover true disease burden, effectiveness, & unmet needs with #RWD that bridges the gap. 📍okt.to/3xP4Bu

💡 Are #atopicdermatitis patients getting access to the therapies they need? Understand treatment patterns and outcomes of patients treated with #dupilumab in this poster highlighting the power of linked #RWD. 📍View the full poster: okt.to/U6aQ1u

📣 We’re excited to announce OM1's expansion into Europe! This step marks a significant milestone in OM1’s mission to improve healthcare decision-making by providing more actionable, data-driven insights across a wider geographic area. 📍Press release: okt.to/P1Wk6E

OM1, Inc. expands #mentalhealth network to over six million patients, enhancing #realworldevidence and #personalizedcare capabilities | Becaris Publishing becarispublishing.com/digital-conten…

📢 New Research Alert from OM1 at #ISPOR2025 🧠 This study highlights the critical role of #RWD and #AI in advancing #pharmacovigilance, regulatory decision-making, and equitable access to treatment. 📄 Full media alert: okt.to/2EShHF #ISPORAnnual #GLP1 #MentalHealth

NEW MEDIA 📣 PhenOM® foundation model trained on more than one billion years of patient health histories, representing the largest model of its kind to date.   📍Full press release: okt.to/lMWQFR #AI #MachineLearning #ISPORAnnual #ISPOR2025 #DigitalPhenotyping

Understanding the link between #GLP1 therapies and suicidal ideation using #RealWorldData | @ISPORAnnual OM1, Inc. becarispublishing.com/digital-conten…